123 related articles for article (PubMed ID: 10854358)
21. [Clinical characteristics of Parkinson's disease in natural population].
Huang JB; Zhang ZX; Wu JX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):19-22. PubMed ID: 12905811
[TBL] [Abstract][Full Text] [Related]
22. Mortality of Parkinson's disease by Hoehn-Yahr stage from community-based and clinic series [Keelung Community-based Integrated Screening (KCIS) no. 17)].
Liou HH; Wu CY; Chiu YH; Yen AM; Chen RC; Chen TF; Chen CC; Hwang YC; Wen YR; Chen TH
J Eval Clin Pract; 2009 Aug; 15(4):587-91. PubMed ID: 19674213
[TBL] [Abstract][Full Text] [Related]
23. [Progress in the basic and clinical aspects of Parkinson's disease].
Mizuno Y
Rinsho Shinkeigaku; 2004 Nov; 44(11):741-50. PubMed ID: 15651281
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.
Lobo A; Launer LJ; Fratiglioni L; Andersen K; Di Carlo A; Breteler MM; Copeland JR; Dartigues JF; Jagger C; Martinez-Lage J; Soininen H; Hofman A
Neurology; 2000; 54(11 Suppl 5):S4-9. PubMed ID: 10854354
[TBL] [Abstract][Full Text] [Related]
25. Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease.
Fernandez HH; Lapane KL
Med Sci Monit; 2002 Apr; 8(4):CR241-6. PubMed ID: 11951064
[TBL] [Abstract][Full Text] [Related]
26. Parkinson's disease mortality among male anesthesiologists and internists.
Peretz C; Alexander BH; Nagahama SI; Domino KB; Checkoway H
Mov Disord; 2005 Dec; 20(12):1614-7. PubMed ID: 16078210
[TBL] [Abstract][Full Text] [Related]
27. Validity of a modified Parkinson's disease screening questionnaire in India: effects of literacy of participants and medical training of screeners and implications for screening efforts in developing countries.
Sarangmath N; Rattihalli R; Ragothaman M; Gopalkrishna G; Doddaballapur S; Louis ED; Muthane UB
Mov Disord; 2005 Dec; 20(12):1550-6. PubMed ID: 16078206
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease.
Racette BA; Rundle M; Parsian A; Perlmutter JS
Am J Med Genet; 1999 Oct; 88(5):539-43. PubMed ID: 10490713
[TBL] [Abstract][Full Text] [Related]
29. The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease.
Haugarvoll K; Aarsland D; Wentzel-Larsen T; Larsen JP
Acta Neurol Scand; 2005 Dec; 112(6):386-90. PubMed ID: 16281921
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of phobic anxiety and risk of Parkinson's disease.
Weisskopf MG; Chen H; Schwarzschild MA; Kawachi I; Ascherio A
Mov Disord; 2003 Jun; 18(6):646-51. PubMed ID: 12784267
[TBL] [Abstract][Full Text] [Related]
31. Population prevalence and incidence of Parkinson's disease in an Australian community.
Mehta P; Kifley A; Wang JJ; Rochtchina E; Mitchell P; Sue CM
Intern Med J; 2007 Dec; 37(12):812-4. PubMed ID: 17561942
[TBL] [Abstract][Full Text] [Related]
32. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
[TBL] [Abstract][Full Text] [Related]
33. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study.
Elbaz A; Peterson BJ; Bower JH; Yang P; Maraganore DM; McDonnell SK; Ahlskog JE; Rocca WA
Mov Disord; 2005 Jun; 20(6):719-25. PubMed ID: 15704188
[TBL] [Abstract][Full Text] [Related]
34. Direct medical costs associated with Parkinson's disease: a population-based study.
Leibson CL; Long KH; Maraganore DM; Bower JH; Ransom JE; O'Brien PC; Rocca WA
Mov Disord; 2006 Nov; 21(11):1864-71. PubMed ID: 16977632
[TBL] [Abstract][Full Text] [Related]
35. Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease.
Rocca WA; Bower JH; Ahlskog JE; Elbaz A; Grossardt BR; McDonnell SK; Schaid DJ; Maraganore DM
Mov Disord; 2007 Aug; 22(11):1607-14. PubMed ID: 17546668
[TBL] [Abstract][Full Text] [Related]
36. Physical activity and the risk of Parkinson disease.
Chen H; Zhang SM; Schwarzschild MA; Hernán MA; Ascherio A
Neurology; 2005 Feb; 64(4):664-9. PubMed ID: 15728289
[TBL] [Abstract][Full Text] [Related]
37. Comorbid conditions associated with Parkinson's disease: a population-based study.
Leibson CL; Maraganore DM; Bower JH; Ransom JE; O'brien PC; Rocca WA
Mov Disord; 2006 Apr; 21(4):446-55. PubMed ID: 16161155
[TBL] [Abstract][Full Text] [Related]
38. Mortality in Parkinson's disease and its association with dementia and depression.
Hughes TA; Ross HF; Mindham RH; Spokes EG
Acta Neurol Scand; 2004 Aug; 110(2):118-23. PubMed ID: 15242420
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Parkinson's disease in Junín, Buenos Aires Province, Argentina.
Melcon MO; Anderson DW; Vergara RH; Rocca WA
Mov Disord; 1997 Mar; 12(2):197-205. PubMed ID: 9087978
[TBL] [Abstract][Full Text] [Related]
40. Frequency and impact of neurologic diseases in the elderly of Europe: A collaborative study of population-based cohorts.
Launer LJ; Hofman A
Neurology; 2000; 54(11 Suppl 5):S1-8. PubMed ID: 10854353
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
